GenMark Licenses HCV Genotyping Patent Estate from Innogenetics

The deal is anticipated to accelerate GenMark's expansion into the largest molecular diagnostics labs in the US and increase the value of its XT-8 multiplex molecular diagnostic platform, the company said.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.